Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp KoreafiledCriticalGreen Cross Corp Japan
Priority to JP11029580ApriorityCriticalpatent/JPS5735521A/ja
Publication of JPS5735521ApublicationCriticalpatent/JPS5735521A/ja
Publication of JPS6236486B2publicationCriticalpatent/JPS6236486B2/ja
Derivaten van cis, endo-2-azabicyclo-(3,3,0)-octaan-3-carbonzuur, werkwijze voor de bereiding daarvan, deze stoffen bevattende middelen en hun toepassing.
Zur selektiven abtrennung von metallkationen aus waessrigen loesungen geeignetes teilchenfoermiges mittel, verfahren zu seiner herstellung und seine verwendung.
Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau